{"organizations": [], "uuid": "72fd1c776c9965146ebf4e32a75e66a57957483e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-menlo-therapeutics-reports-qtrly-l/brief-menlo-therapeutics-reports-qtrly-loss-per-share-0-72-idUSASC0A13Z", "country": "US", "domain_rank": 408, "title": "BRIEF-Menlo Therapeutics Reports Qtrly Loss Per Share $0.72", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-09T23:16:00.000+03:00", "replies_count": 0, "uuid": "72fd1c776c9965146ebf4e32a75e66a57957483e"}, "author": "", "url": "https://www.reuters.com/article/brief-menlo-therapeutics-reports-qtrly-l/brief-menlo-therapeutics-reports-qtrly-loss-per-share-0-72-idUSASC0A13Z", "ord_in_thread": 0, "title": "BRIEF-Menlo Therapeutics Reports Qtrly Loss Per Share $0.72", "locations": [], "entities": {"persons": [{"name": "menlo therapeuti", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "cs inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " Updated 10 minutes ago BRIEF-Menlo Therapeutics Reports Qtrly Loss Per Share $0.72 Menlo Therapeutics Inc:\n* MENLO THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS * QTRLY LOSS PER SHARE $0.72\n* LOWERING ITS OPERATING EXPENSE GUIDANCE FOR FULL YEAR 2018 TO A RANGE OF APPROXIMATELY $68.0 MILLION TO $78.0 MILLION ", "external_links": [], "published": "2018-05-09T23:16:00.000+03:00", "crawled": "2018-05-09T23:30:44.042+03:00", "highlightTitle": ""}